| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
May 09, 2023 |
|
|
| |
|
|
| |
|
|
|
Xtalks, online
2023 -5-15
This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization, it is clear that newer technologies such as accelerometers and video have the ability to passively or proactively gather more patient data. These wearable devices offer significant advantages in terms of capturing comprehensive and detailed information, ultimately informing the safety and efficacy of study drugs.
In this webinar, the featured speakers will take a look at the key decision drivers for consideration in deploying wearables as a means to further gather patient data, including both technical hardware considerations and regulatory requirements.
Join this webinar to learn about the benefits and considerations of utilizing wearable devices for improving eCOA patient data capture in clinical trials.
Key Takeaways:
eCOA trends including wearables
Wearable hardware: What does the ISO-13485:2016 certification mean and are all devices certified?
Is the 510K registration required?
Considerations for implementing wearables with the current eCOA strategy
Alarms and alerts considerations for including them into current eCOA solution
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Mark Wade, Global Practice Leader, TransPerfect Life Sciences, COA SME Sylvain Zorman, Director of Digital Health Sciences, ActiGraph Kyle Hogan, President, Datacubed Health
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -5-15
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|